Mn Services Vermogensbeheer B.V. boosted its position in CME Group (NASDAQ:CME) by 1.1% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 53,483 shares of the financial services provider’s stock after purchasing an additional 600 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in CME Group were worth $8,650,000 as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. ARK Investment Management LLC bought a new stake in CME Group in the 4th quarter worth about $120,000. Signaturefd LLC bought a new position in shares of CME Group during the 1st quarter valued at approximately $138,000. AlphaOne Investment Services LLC bought a new position in shares of CME Group during the 4th quarter valued at approximately $146,000. Mosaic Family Wealth LLC bought a new position in shares of CME Group during the 4th quarter valued at approximately $146,000. Finally, Truewealth LLC bought a new position in shares of CME Group during the 4th quarter valued at approximately $157,000. 82.12% of the stock is owned by institutional investors and hedge funds.
In related news, Chairman Terrence A. Duffy sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 22nd. The shares were sold at an average price of $161.00, for a total value of $3,220,000.00. Following the completion of the transaction, the chairman now directly owns 94,686 shares of the company’s stock, valued at approximately $15,244,446. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Jeffrey M. Bernacchi sold 3,815 shares of the stock in a transaction that occurred on Tuesday, May 22nd. The stock was sold at an average price of $161.04, for a total transaction of $614,367.60. Following the completion of the sale, the director now owns 58,607 shares in the company, valued at $9,438,071.28. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 26,315 shares of company stock valued at $4,236,918. 0.57% of the stock is owned by insiders.
CME Group opened at $159.60 on Friday, according to MarketBeat. The company has a market capitalization of $54.17 billion, a P/E ratio of 29.56, a price-to-earnings-growth ratio of 2.24 and a beta of 0.57. CME Group has a 12 month low of $116.55 and a 12 month high of $171.71. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.10.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, April 26th. The financial services provider reported $1.86 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.85 by $0.01. The company had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.12 billion. CME Group had a net margin of 111.45% and a return on equity of 8.48%. CME Group’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same period last year, the firm earned $1.22 EPS. equities analysts expect that CME Group will post 6.79 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 25th. Investors of record on Friday, June 8th will be issued a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 1.75%. The ex-dividend date of this dividend is Thursday, June 7th. CME Group’s dividend payout ratio (DPR) is presently 58.70%.
A number of research firms have recently weighed in on CME. Sandler O’Neill reissued a “buy” rating and set a $175.00 target price on shares of CME Group in a research report on Friday, February 2nd. Barclays increased their target price on shares of CME Group from $170.00 to $175.00 and gave the company an “overweight” rating in a research report on Friday, February 2nd. BidaskClub downgraded shares of CME Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 28th. Bank of America increased their target price on shares of CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a research report on Friday, February 2nd. Finally, Citigroup reissued a “buy” rating and set a $172.00 target price (up from $155.00) on shares of CME Group in a research report on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $165.57.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.